The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Pathology of Berkeley sickle cell mice: similarities and differences with human sickle cell disease
Open accessAbstract
Because Berkeley sickle cell mice are used as an animal model for human sickle cell disease, we investigated the progression of the histopathology in these animals over 6 months and compared these findings to those published in humans with sickle cell disease. The murine study groups were composed of wild-type mixed C57Bl/6-SV129 (control) mice and sickle cell (SS) mice (alpha-/-, beta-/-, transgene +) of both sexes and between 1 and 6 months of age. SS mice were similar to humans with sickle cell disease in having erythrocytic sickling, vascular ectasia, intravascular hemolysis, exuberant hematopoiesis, cardiomegaly, glomerulosclerosis, visceral congestion, hemorrhages, multiorgan infarcts, pyknotic neurons, and progressive siderosis. Cerebral perfusion studies demonstrated increased blood-brain barrier permeability in SS mice. SS mice differed from humans with sickle cell disease in having splenomegaly, splenic hematopoiesis, more severe hepatic infarcts, less severe pulmonary manifestations, no significant vascular intimal hyperplasia, and only a trend toward vascular medial hypertrophy. Early retinal degeneration caused by a homozygous mutation (rd1) independent from that causing sickle hemoglobin was an incidental finding in some Berkeley mice. While our study reinforces the fundamental strength of this model, the notable differences warrant careful consideration when drawing parallels to human sickle cell disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Young sickle mice do not commonly develop large-vessel vasculopathy and stroke (153, 154)”
From Pathophysiology of Sickle Cell Disease (2019) · cites this paper as [153]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adams, R. J., McKie, V. C., Hsu, L., Files, B., Vichinsky, E., Pegelow, C., Abboud, M., Gallagher, D., Kutlar, A., Nichols, F. T., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807023390102 · Cited by 1,866
Cerebrovascular accidents in sickle cell disease: rates and risk factors.
(1998) · PubMed · doi:10.1182/blood.v91.1.288 · Cited by 1,694
Dams, R. O. J. A., Ie, V. I. C. M. C. K., Su, L. E. H., Iles, B. E. F., Ichinsky, E. L. V., Egelow, C. H. P., Bboud, M. I. A., Allagher, D. I. G., Utlar, K., Ichols, F. E. T. N., et al. (2015) · Cited by 1,338
Causes and Outcomes of the Acute Chest Syndrome in Sickle Cell Disease
Vichinsky, E. P., Neumayr, L. D., Earles, A. N., Williams, R., Lennette, E. T., Dean, D., Nickerson, B., Orringer, E., McKie, V., Bellevue, R., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006223422502 · Cited by 1,234
Self-citationRetinal degeneration mutants in the mouse
Chang, B., Hawes, N. L., Hurd, R. E., Davisson, M. T., Nusinowitz, S., & Heckenlively, J. R. (2002) · Vision Research · doi:10.1016/s0042-6989(01)00146-8 · Cited by 840
Acute Chest Syndrome in Sickle Cell Disease: Clinical Presentation and Course
Vichinsky, E. P., Styles, L. A., Colangelo, L. H., Wright, E. C., Castro, O., Nickerson, B., & Disease, T. C. S. O. S. C. (1997) · Blood · doi:10.1182/blood.v89.5.1787 · Cited by 573
Pittler, S. J., & Baehr, W. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.19.8322 · Cited by 562
Differential effect of the rd mutation on rods and cones in the mouse retina.
Carter‐Dawson, L. D., LaVail, M. M., & Sidman, R. L. (1978) · PubMed · Cited by 495
Transgenic Knockout Mice with Exclusively Human Sickle Hemoglobin and Sickle Cell Disease
Pászty, C., Brion, C. M., Manci, E., Witkowska, H. E., Stevens, M. E., Mohandas, N., & Rubin, E. M. (1997) · Science · doi:10.1126/science.278.5339.876 · Cited by 467
Self-citationOcclusion of Large Cerebral Vessels in Sickle-Cell Anemia
STOCKMAN, J. A., Nigro, M. A., Mishkin, M. M., & Oski, F. A. (1972) · New England Journal of Medicine · doi:10.1056/nejm197210262871703 · Cited by 333
Research works printed but not linked: 4
- [12]12. Fabry ME, Suzuka SM, Aggarwal S, Nagel RL. Unexpected impact of HbF on mean survival time of BERK sickle transgenic mice expressing exclu- sively human hemoglobins [abstract]. Blood. 2002;100:2617a.
- [13]13. Noguchi CT, Gladwin MT, Diwan B, et al. Devel- oping a useful model for sickle cell disease: hem- izygotes for the mouse beta-globin gene [abstract]. Blood. 2000;96:598a.
- [30]30. Hardison JE, Rogers CM. Cardiovascular mani- festations of sickle cell anemia. In: Hurst JW, ed. The Heart. New York, NY: McGraw-Hill; 1979: 195.
- [41]41. Rothman S, Nelson JS. Stenosis of large caliber intracranial arteries and cerebral infarctions in sickle cell anaemia. Lab Invest. 1978;38:392.
Cited by
Sorted by citations
Items 101–149 of 149
Almeida, L. E. F., Wang, L., Kamimura, S., Zerfas, P. M., Smith, M. L., Neto, O. L. A., Vale, T., Quezado, M., Horkayne‐Szakaly, I., Wakim, P., et al. (2020) · Brain Research · doi:10.1016/j.brainres.2020.146968 · Cited by 8
Madabushi, S. S., Fouda, R., Ghimire, H., Abdelhamid, A. M. H., Lim, J. E., Vishwasrao, P., Kiven, S. B., Brooks, J., Zuro, D. M., Rosenthal, J., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.969429 · Cited by 7
Metabolic correlates to critical speed in murine models of sickle cell disease
Cendali, F. I., Nemkov, T. G., Lisk, C., LaCroix, I. S., Nouraie, M. S., Zhang, Y., Gordeuk, V. R., Buehler, P. W., Irwin, D. C., & D’Alessandro, A. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1151268 · Cited by 6
Inusa, B. P. D., Lodi, M., Palazzi, G., & Ataga, K. I. (2018) · InTech eBooks · doi:10.5772/intechopen.76588 · Cited by 7
Li, J., Jeong, S., Xiong, B., Tseng, A., Mahon, A. B., Isaacman, S., Gordeuk, V. R., & Cho, J. (2019) · Haematologica · doi:10.3324/haematol.2019.226720 · Cited by 8
The Relevance of Genetically Altered Mouse Models of Human Disease
Bhogal, N., & Combes, R. D. (2006) · Alternatives to Laboratory Animals · doi:10.1177/026119290603400401 · Cited by 7
Lisk, C., Cendali, F. I., Setua, S., Thangaraju, K., Pak, D. I., Swindle, D. C., Dzieciątkowska, M., Gamboni, F., Hassell, K. L., Nuss, R., et al. (2023) · Journal of Proteome Research · doi:10.1021/acs.jproteome.3c00224 · Cited by 6
Jin, B., Kumari, T., Lee, J., Kim, J.-S., Bokorová, R., Gheware, A., Ripoll, C. V., Sargazi, A., Jeong, S., Hyun, Y., et al. (2026) · Cardiovascular Research · doi:10.1093/cvr/cvag003 · Cited by 4
Abid, S., Kebe, K., Houssaïni, A., Tomberli, F., Marcos, É., Bizard, E., Breau, M., Parpaleix, A., Tissot, C.-M., Maître, B., et al. (2018) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000570 · Cited by 4
Tofovic, S. P. (2023) · Medical Hypotheses · doi:10.1016/j.mehy.2023.111045 · Cited by 4
Lisk, C., Cendali, F. I., Pak, D. I., Swindle, D. C., Hassell, K. L., Nuss, R., George, G., Davizon‐Castillo, P., Buehler, P. W., D’Alessandro, A., et al. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1149005 · Cited by 4
Rana, N. K., Lisk, C., Cendali, F. I., Lucero, M. J., Grier, A., Setua, S., Thangaraju, K., Khan, A., Reisz, J. A., Dzieciątkowska, M., et al. (2025) · Journal of Proteome Research · doi:10.1021/acs.jproteome.4c00814 · Cited by 3
Yalamanoglu, A., Dubach, I. L., Schulthess-Lutz, N., Ingoglia, G., Swindle, D. C., Humar, R., Schaer, D. J., Buehler, P. W., Irwin, D. C., & Vallelian, F. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.627944 · Cited by 3
Franks, T. M., Haugabook, S. J., Ottinger, E. A., Vermillion, M. S., Pawlik, K. M., Townes, T. M., & Rogers, C. S. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.09.15.291864 · Cited by 4
Sickle Cell Disease Erythrocyte Stiffness and Cytoadhesion Investigated via Atomic Force Microscopy
Maciaszek, J. L. (2013) · OpenCommons at University of Connecticut (University of Connecticut) · Cited by 3
Munoz, C. J., Pires, I. S., Lucas, D., Muller, C. R., Martinez, J., Gopal, S., Palmer, A. F., & Cabrales, P. (2026) · Blood Advances · doi:10.1182/bloodadvances.2025018529 · Cited by 2
PATHOPHYSIOLOGY OF HEMOGLOBIN AND ITS DISORDERS
Steinberg, M. H. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511596582.012 · Cited by 3
Cui, M., Billett, H. H., Suzuka, S. M., Ambadipudi, K., Archarya, S., Mowrey, W. B., & Branch, C. A. (2022) · Translational research · doi:10.1016/j.trsl.2022.01.003 · Cited by 2
Behavioral and transcriptional effects of age in HbSS-BERK humanized SCD mice
Goldsborough, K. N., Taylor, M., Mckiver, B. D., Muchhala, K. H., Sonenklar, M., Adu-Gyamfi, A. A., Herz, S. M., Jessup, D., Lloyd, J. A., Akbarali, H. I., et al. (2025) · Journal of sickle cell disease. · doi:10.1093/jscdis/yoaf033 · Cited by 1
Pulmonary Hypertension Associated With Sickle Cell Disease and Schistosomiasis
Mickael, C. S., Kabwe, J. C., Balladares, D. C. F., Bai, A. S., Nolan, K., Lee, M. H., Kumar, R., Hilton, J. F., Phiri, J., Musonda, T., et al. (2025) · Pulmonary Circulation · doi:10.1002/pul2.70230 · Cited by 1
You, W., An, Q., Guo, D., Huang, Z., Guo, L., Chen, Z., Xu, H., Wang, G., Weng, Y., Ma, Z., et al. (2023) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2023.168743 · Cited by 1
Shrestha, A., Pillis, D. M., Felker, S., Chi, M., Wagner, K., Gbotosho, O. T., Sieling, J., Shadid, M., & Malik, P. (2025) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2025.101439 · Cited by 1
Cardiorespiratory pathogenesis of sickle cell disease in a mouse model
Ren, J. T., Ding, X., Trudel, M., Greer, J. J., & MacLean, J. E. (2017) · Scientific Reports · doi:10.1038/s41598-017-08860-8 · Cited by 1
Rescuing Decrepit Soluble Guanylate Cyclase: A Therapy for Sickle Cell Disease?
Schumacker, P. T. (2018) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2018-0003ed · Cited by 1
Genomic Characterization of Sickle Cell Mouse Models for Therapeutic Genome Editing Applications
Woodard, K. J. (2021) · doi:10.21007/etd.cghs.2021.0540 · Cited by 1
Animal Models of Hemoglobinopathies and Thalassemia
Fabry, M. E. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511596582.017
Do CD40L and CD40 Contribute to Sickle Cell Anemia?
Yeboah, S. A. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/qawd-9344
C-Reactive Protein and Interleukin-6 Are Decreased in Transgenic Sickle Cell Mice
Archer, D. R., Stiles, J. K., Newman, G. W., Quarshie, A., Hsu, L. L.-Y., Sayavongsa, P., Perry, J., Jackson, E., & Hibbert, J. M. (2008)
Wagner, M. C. (2006) · SMARTech Repository (Georgia Institute of Technology)
Thalassemia and sickle cell disease
Roberts, I. A. G., & de la Fuente, J. (2009) · Elsevier eBooks · doi:10.1016/b978-0-443-10147-2.50021-7
Approaches for Analysis of Erythroid Cell Parameters and Hemoglobinopathies in Mouse Models
Trudel, M., & Sedzro, J.-C. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7428-3_6
GBT440 Increases Hematocrit and Improves Biventricular Function in Berkeley Sickle Cell Disease Mice
Gassner, R., Schreier, D. A., Hacker, T. A., Tabima, D. M., & Chesler, N. C. (2020) · Journal of Biomechanical Engineering · doi:10.1115/1.4049079
Rós, F. A. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2021.tde-04102021-161614
Tinguely, M., Opitz, L., Schaer, D. J., Vallelian, F., Schmugge, M., & Franzoso, F. D. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.09.26.559266
Tinguely, M., Opitz, L., Schaer, D. J., Vallelian, F., Schmugge, M., & Franzoso, F. D. (2023) · Research Square · doi:10.21203/rs.3.rs-3615607/v1
Gotardo, É. M. F., Torres, L. S., Förster, I., Gushiken, L. F. S., de Brito, P. L., Leonardo, F. C., Zaidan, B. C., Bruederle, A., Agoulnik, S. I., Kovařík, J., et al. (2025) · Experimental Hematology · doi:10.1016/j.exphem.2025.105366
Mechanisms of delayed wound healing in various models of human diseases
Nguyen, V. T. (2015) · theses.fr (ABES) · doi:10.70675/ef58963ez0008z4633zbd9azd255022aa1be · Cited by 1
The paradox of HbSC disease—Not so benign after all
Lyde, R. B., & Novelli, E. M. (2026) · Seminars in Hematology · doi:10.1053/j.seminhematol.2026.05.001
Chronic pain in sickle cell disease: a role for lysophosphatidic acid
Viatchenko‐Karpinski, V., Khasabova, I. A., Johns, M. E., Neal, L., Tang, K., Golovko, M. Y., Golovko, A. M., Anjum, S., Gupta, K., Khasabov, S. G., et al. (2026) · Blood · doi:10.1182/blood.2025031738
Simplified Procedure for Isolation and Culture of Neuronal Cells from Brains of Sickle Cell Mice
Goel, Y., Arellano, M. A., O'Daniel, K., Argueta, D. A., Lomeli, R. A., Lomeli, N., Ordaz, D. A., Bota, D. A., Kumaresan, V., & Gupta, K. (2026) · Cells · doi:10.3390/cells15110976
Metadata
- Authors
- Manci, E. A.
- Affiliations
- Johns Hopkins University (US)
- Corresponding author
- Manci, E. A.
- ORCID
- Manci, E. A.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2006-02-15
- Volume
- 107
- Issue
- 4
- Pages
- 1651-1658
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- PMC
- PMC1895417
- OpenAlex
- W2066774936
- Cited by
- 149
- References
- 48
- Citations by year
- 2026: 5 · 2025: 7 · 2024: 2 · 2023: 11 · 2022: 8 · 2021: 10 · 2020: 9 · 2019: 10 · 2018: 12 · 2017: 10 · 2016: 10 · 2015: 9 · 2014: 7 · 2013: 5 · 2012: 5
- FWCI
- 1.93
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Blood (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Stony Brook University
- National Institutes of Health (n01hb007086-007)
- National Heart, Lung, and Blood Institute (P01HL044612, HL70981, HL 19278, N0-1-HB07086, R01HL070981, HL-44612, HL45922, R01HL019278, R01HL045922)
- National Institute of Neurological Disorders and Stroke (NS 43324, R01NS043324)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Health Sciences › Medicine › Hematology › Blood properties and coagulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Hemoglobin structure and function
- Keywords
- sickle cell disease, animal models, histopathology, angiodysplasia, intravascular hemolysis, cardiomegaly, glomerulosclerosis, splenomegaly, retinal degeneration, siderosis
- MeSH terms
- Anemia, Sickle Cell, Animals, Body Weight, Humans, Mutation, Organ Size, Reference Values, Species Specificity, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
